US CORE Graduate Intern

At Genmab, we are dedicated to building extra[not]ordinary® futures, together, by developing antibody products and groundbreaking, knock-your-socks-off KYSO antibody medicines® that change lives and the future of cancer treatment and serious diseases. We strive to create, champion and maintain a global workplace where individuals’ unique contributions are valued and drive innovative solutions to meet the needs of our patients, care partners, families and employees.

Our people are compassionate, candid, and purposeful, and our business is innovative and rooted in science. We believe that being proudly authentic and determined to be our best is essential to fulfilling our purpose. Yes, our work is incredibly serious and impactful, but we have big ambitions, bring a ton of care to pursuing them, and have a lot of fun while doing so.

Does this inspire you and feel like a fit? Then we would love to have you join us!

Job Title

US CORE Graduate Intern

Why Genmab

At Genmab, interns don’t just learn about the work - they help move it forward. Our internship program provides meaningful, hands-on experience through real projects that directly support our teams, business priorities, and mission to transform the lives of people with cancer and other serious diseases.

From day one, interns are welcomed as part of the team and given opportunities to contribute, collaborate, and make an impact. Along the way, you’ll learn from talented colleagues and senior leaders, build new skills, expand your professional network, and gain exposure to the innovative work happening across Genmab.

We’re always looking for smart, curious, purpose-led people who are ready to bring fresh perspectives and bold ideas. Explore our website to learn more about Genmab and how you could play a role in our bold, extra[not]ordinary® future.

Job Overview

The US Center for Outcomes Research, Real World Evidence & Epidemiology (US CORE) team within US Medical Affairs develops evidence generation strategies informed by US payer needs, executes research, and creates payer-facing materials to support understanding of product value propositions. The intern will contribute to these activities across the oncology portfolio by assessing payer evidence needs, supporting research projects, and translating findings into clear materials for healthcare decision-makers.

What you’ll do

• Review published literature and US payer insights to identify evidence needs related to clinical outcomes, economic burden, and patient experience.
• Contribute to evidence generation strategy for head and neck cancer by mapping payer questions to existing and planned research and identifying gaps in the evidence supporting product value propositions.
• Support execution of health economics and outcomes research projects, including reviewing research protocols, study deliverables, and findings with US CORE colleagues.
• Help develop and update payer-facing materials, such as dossiers, value communications, and disease burden resources.

Required qualifications, capabilities and skills

• Currently enrolled in an accredited degree program in public health, health economics, epidemiology, biology or other science programs, health services research, outcomes research, biostatistics, pharmacy, or a related discipline.
• Completed coursework in research methods, epidemiology, statistics, health economics, or a related area.
• Ability to organize and summarize quantitative and qualitative information in evidence tables, written summaries, and presentations.
• Ability to document sources accurately and distinguish research findings from interpretation.
• Ability to manage a defined project, incorporate feedback, and meet agreed deadlines within a 10-week internship.

Preferred qualifications, capabilities and skills

• Academic or research experience in health economics and outcomes research, real-world evidence, epidemiology, or health services research.
• Familiarity with oncology, cancer treatment pathways, or the evidence needs of US payers and healthcare systems.
• Experience with claims or electronic health record data, patient-reported outcomes, patient preference research, or economic models.
• Experience developing literature reviews, research protocols, scientific abstracts, posters, or manuscripts.

General Intern Information – Date/Location/Schedule

Internships will take place over 10 weeks from June – August 2027. This role will be based in Princeton, NJ and operate on a required hybrid schedule – 3 days in the office and 2 days remote per week. This role is not eligible for work visa sponsorship at the time of the application or in the future.

What’s next?

Help us learn about you by submitting a complete and thoughtful application, which includes your resume. Your application and resume are a way for us to initially get to know you, so it’s important to complete all relevant questions to ensure we have as much information about you as possible.

Every application matters to us, and we’ll carefully review each submission as quickly as possible to see if your qualifications align with the role. While we’re unable to provide individual updates, rest assured that we’re working diligently to move through the process efficiently.

If you move forward in the process, you’ll receive an email invitation to connect with us and dive deeper into this exciting opportunity. The final stage will bring selected candidates meeting directly with our hiring teams, where you’ll have the chance to showcase your potential. We are committed to keeping you informed and will share decisions with all candidates as soon as we are able. We can't wait to see where this journey takes you!

About Genmab

Genmab is an international biotechnology company with a core purpose to improve the lives of patients through innovative and differentiated antibody therapeutics. For 25 years, its hard-working, innovative and collaborative team has invented next-generation antibody technology platforms and harnessed translational, quantitative and data sciences, resulting in a proprietary pipeline including bispecific T-cell engagers, antibody-drug conjugates, next-generation immune checkpoint modulators and effector function-enhanced antibodies. By 2030, Genmab’s vision is to transform the lives of people with cancer and other serious diseases with Knock-Your-Socks-Off (KYSO®) antibody medicines.

Established in 1999, Genmab is headquartered in Copenhagen, Denmark with international presence across North America, Europe and Asia Pacific. For more information, please visit Genmab.com and follow us on LinkedIn and X.

Genmab is committed to protecting your personal data and privacy. Please see our privacy policy for handling your data in connection with your application on our website Job Applicant Privacy Notice (genmab.com).